monoamine oxidase A
OMIM: 309850, Gene2Phenotype
Panel | Reviews | Mode of inheritance | Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAOA in Neurotransmitter disorders
Level 3: Motor Disorders of the CNS
|
review | X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Sudden death in young people
Level 3: Cardiac arrhythmia
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
Tags |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Autism
|
review | Not set |
Sources
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Undiagnosed metabolic disorders
Level 3: Specific metabolic abnormalities
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Likely inborn error of metabolism - targeted testing not possible
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Fetal anomalies
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in DDG2P
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Intellectual disability - microarray and sequencing
Level 3: Neurodevelopmental disorders
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Childhood onset dystonia, chorea or related movement disorder
|
review | X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) |
Sources
Phenotypes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAOA in Severe Paediatric Disorders
|
review | X-LINKED: hemizygous mutation in males, biallelic mutations in females |
Sources
Phenotypes
|